SynthesisBMC infectious diseases2026

Real-world untreated risk of hospitalization and death in a nirmatrelvir/ritonavir treatment-eligible population with mild-to-moderate COVID-19 in the United States: a systematic literature review.

Kristen Migliaccio-Walle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.